Chief Executive Officer
CurrentAlphageneron Pharmaceuticals Inc., (“Alphageneron”) is a private clinical stage biopharmaceutical company advancing Natural Killer Cell (“NK Cell”) immunotherapies for hematologic cancers or solid tumors; and, viral infections (including COVID-19).